Payments to Acquire Property, Plant, and Equipment of Fulcrum Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Fulcrum Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Fulcrum Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Fulcrum Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $314,000, a 13% increase from 2024.
  • Fulcrum Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $278,000, a 45% decline from 2023.
  • Fulcrum Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $508,000, a 74% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Fulcrum Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $314,000 +$36,000 +13% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $278,000 -$230,000 -45% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $508,000 -$1,455,000 -74% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025 2024 FY
2022 $1,963,000 +$250,000 +15% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2024 2023 FY
2021 $1,713,000 +$371,000 +28% 01 Jan 2021 31 Dec 2021 10-K/A 26 Jun 2023 2022 FY
2020 $1,342,000 +$489,000 +57% 01 Jan 2020 31 Dec 2020 10-K/A 26 Jun 2023 2021 FY
2019 $853,000 -$8,128,000 -91% 01 Jan 2019 31 Dec 2019 10-K/A 23 Jun 2023 2020 FY
2018 $8,981,000 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY

Fulcrum Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$28,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $28,000 -$143,000 -84% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $171,000 -$75,000 -30% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $246,000 -$16,000 -6.1% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $262,000 -$305,000 -54% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $567,000 +$257,000 +83% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $310,000 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.